Largest and longest studies of any FDA-approved treatment for GA

Slows GA progression with an increasing effect over time. The greatest difference was seen during the last 6 months

Proven to slow GA lesion growth

Only SYFOVRE slows GA in as few as 6 doses per year*

*Your doctor will decide how often you receive SYFOVRE (once every 25-60 days).

SYFOVRE was studied in 2 clinical studies with over 1200 people.

Compared to those untreated, after 2 years SYFOVRE slowed GA lesion growth by 17% (every other month) to 22% (monthly). After 2 years, SYFOVRE slowed GA progression by 18% and 22% (monthly) (n=402) and by 17% and 18% (every other month) (n=406) compared to those untreated. Compared to those untreated, after 2 years SYFOVRE slowed GA lesion growth by 17% (every other month) to 22% (monthly). After 2 years, SYFOVRE slowed GA progression by 18% and 22% (monthly) (n=402) and by 17% and 18% (every other month) (n=406) compared to those untreated.

*After 2 years, SYFOVRE slowed GA progression by 18% and 22% (monthly, 403 patients) or by 17% and 18% (every other month, 406 patients) compared to those untreated.

Getting on treatment can make a difference in slowing GA progression, so if you've been diagnosed, don't wait. Talk to your doctor and take action now. — Rob, real SYFOVRE patient Getting on treatment can make a difference in slowing GA progression, so if you've been diagnosed, don't wait. Talk to your doctor and take action now. — Rob, real SYFOVRE patient

Take action to slow GA with SYFOVRE.